A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

por Harries, M, Moss, C, Perren, T, Gore, M, Hall, G, Everard, M, A'Hern, R, Gibbens, I, Jenkins, A, Shah, R, Cole, C, Pizzada, O, Kaye, S
Publicado 2004